Advertisement

Topics

Earnings in the U.S. Middle Market Grew by 13% in Q4 2018, According to the Golub Capital ...

17:27 EST 11 Jan 2019 | BioMedReports - Blog

NEW YORK, Jan. 11, 2019 /PRNewswire/ -- Middle market private companies in the Golub Capital Altman Index experienced year-over-year earnings growth of 13.4% and revenue

Read more...

Original Article: Earnings in the U.S. Middle Market Grew by 13% in Q4 2018, According to the Golub Capital ...

NEXT ARTICLE

More From BioPortfolio on "Earnings in the U.S. Middle Market Grew by 13% in Q4 2018, According to the Golub Capital ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...